Bringing a new level of sensitivity, speed and versatility to preclinical imaging, the In-Vivo Xtreme II™ offers researchers greater scope to discover important biological mechanisms in disease, treatments and monitoring.
Five imaging modalities are provided as standard, allowing co-registration of molecular events with access to Bioluminescence, Multispectral VIS- NIR Fluorescence, unique Direct Radioisotopic Imaging, and Cherenkov radiation. A high speed digital X-ray with industry leading resolution and reflectance modes enhances data acquisition with anatomical features.
High speed switching between modalities, settings, and camera readout rates, give access to higher temporal resolution in standalone and multimodal imaging applications for dynamic imaging and biodistribution studies. Furthermore, the option to utilize Bruker’s advanced Multimodal Animal Transport Imaging Cassettes and platform specific adaptors to fuse images across Bruker’s entire preclinical imaging portfolio, incorporating Optical, MRI, MPI, PET, SPECT and CT, supports custom combinations for deeper insights and quantitative analysis tuned to the investigation in question.